Log in to your Inderes Free account to see all free content on this page.
Cessatech
12.32 DKK
+0.16 %
Less than 1K followers
CESSA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+0.16 %
+4.41 %
+11.59 %
-16.30 %
+4.41 %
-0.24 %
+545.03 %
-
+14.24 %
Cessatech operates in the pharmaceutical industry. The company specializes in research and development of analgesic nasal sprays that are also used for the treatment of acute pain conditions in children. In addition to the main business, associated ancillary services and related products are also offered. The business is operated globally with the largest presence in the Nordic market. Cessatech was founded in 2020 and is headquartered in Copenhagen.
Read moreMarket cap
228.86M DKK
Turnover
202.32K DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27.2.
2026
Annual report '25
All
Press releases
ShowingAll content types
Cessatech: CT001 soon available for US hospitals in collaboration with STAQ Pharma, for acute pain management in children
Cessatech: Second Quarter Report Q2-2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio